Press Releases
Search
-
09 May 2007
bioMérieux and NuGEN Technologies Announce Cross-License and Supply Agreement. bioMérieux Chooses NuGEN WT-Ovation™ RNA Amplification System For Microarray-based Cancer Assay Development
Marcy l'Etoile, France and San Carlos, California - May 9, 2007. bioMérieux (Euronext: BIM), a world leader in the field of in vitro diagnostics, and NuGEN Technologies, Inc., a privately held company...
-
30 Apr 2007
LabTech Systems Ltd secures strategic private placement with bioMérieux
Adelaide (Australia) / Marcy l’Etoile (France) - april 30, 2007. LabTech Systems Ltd (ASX: LBT), an Australian health care equipment and services company, and bioMérieux (Euronext: BIM), a major playe...
-
23 Apr 2007
bioMérieux - Premier trimestre 2007 - Chiffre d’affaires : + 6,8%, à devises et périmètre constants
Marcy l'Etoile, France - April 23, 2007. bioMérieux (Euronext: BIM), a global leader in the field of in vitro diagnostics, today released its business review for the first three months of 2007.
-
23 Apr 2007
bioMérieux Launches a Molecular Biology Test for the Detection of HPV, a Major Cause of Cervical Cancer
Marcy l’Etoile, France - April 23, 2007. bioMérieux (Euronext: BIM) announces the launch of its NucliSENS EasyQ® HPV; this molecular diagnostic test enables the detection of human papillomavirus (HPV)...
-
18 Apr 2007
bioMérieux and LabTech Systems sign exclusive worldwide license agreement for innovative robotic microbiological instrumentation
Marcy l’Etoile (France)/Adelaide (Australia) - Apr. 18, 2007. LabTech Systems Ltd (ASX: LBT), an Australian health care equipment and services company, and bioMérieux (Euronext: BIM), a world leader i...
-
04 Apr 2007
bioMérieux Innovates Further in the Fight against AIDS The company Launches a Rapid Test, VIKIA® HIV 1 / 2
04/05/2007. A world leader in the field of in vitro diagnostics, bioMérieux confirms its constant commitment to the fight against AIDS with the launch of VIKIA® HIV 1 / 2, a rapid test for the detecti...